Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × pidilizumab × Clear all

NCT02530125 2018-03-19

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

Phase 2 Terminated

4 enrolled 8 charts

Lymphoma, Large B-Cell, Diffuse

NCT00532259 2014-09-12

CT-011 MAb in DLBCL Patients Following ASCT

Phase 2 Completed

72 enrolled 9 charts

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse